BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4610055)

  • 1. A modified technique of preparing mouse-liver nuclei for the detection of antinuclear antibodies (ANA) by immunofluorescence.
    Yantorno C; Riera CM; Risenberg A; Strussberg A
    J Immunol Methods; 1974 Aug; 5(3):253-7. PubMed ID: 4610055
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable reactivity of antinuclear immunoglobulins with cell nuclei of various origin and quality.
    Zitńan D; Cebecauer L
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):303-12. PubMed ID: 4921006
    [No Abstract]   [Full Text] [Related]  

  • 3. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN; Malaviya AN
    Indian J Med Res; 1976 Jun; 64(6):895-902. PubMed ID: 789235
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD; Kerby GP
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation of a standard for antinuclear antibodies].
    Savitskaia KI; Shakhanina KL; Karmysheva VIa; Rakhinskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):68-73. PubMed ID: 339616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibodies. I. Patterns of nuclear immunofluorescence.
    Burnham TK; Bank PW
    J Invest Dermatol; 1974 May; 62(5):526-34. PubMed ID: 4595992
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of antinuclear factors in rheumatic diseases].
    Ménard HA; Myhal D; Camerlain M; Lussier A
    Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 10. Antinuclear antibodies. Clinical significance of titers and fluorescence patterns.
    Husain M; Neff J; Daily E; Townsend J; Lucas F
    Am J Clin Pathol; 1974 Jan; 61(1):59-65. PubMed ID: 4128966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies to extractable nuclear antigens in rheumatic diseases].
    Ivanova SM; Ivanova MM; Speranskiĭ AI
    Ter Arkh; 1980; 52(6):59-62. PubMed ID: 7404390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serological diagnosis of systemic connective tissue inflammation; a new immunofluorescence method for demonstrating antinuclear antibodies].
    Scagliusi P; Laghezza D; Ferrari G; Fasiello V; De Lucia M
    Minerva Med; 1981 Jan; 72(2):81-90. PubMed ID: 7007926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
    Webb J; Whaley K; Lee P
    Scott Med J; 1974 Jul; 19(4):171-5. PubMed ID: 4209789
    [No Abstract]   [Full Text] [Related]  

  • 15. ANTINUCLEAR ANTIBODIES IN FAMILIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    POLLAK VE
    N Engl J Med; 1964 Jul; 271():165-71. PubMed ID: 14158353
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical research in diffuse reactive mesenchymopathies. Results and interpretative speculations].
    Grimaldi MG
    Recenti Prog Med; 1969 Feb; 46(2):133-69. PubMed ID: 4893918
    [No Abstract]   [Full Text] [Related]  

  • 18. [Autoallergic diseases. II].
    Feo F
    Minerva Med; 1978 Oct; 69(51):3546-9. PubMed ID: 83553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.